Drugmaker Aegerion’s Chapter 11 plan confirmed in New York
Bankrupt US drugmaker Aegerion’s Chapter 11 plan, which envisages it sold to European rival Amryt Pharma, has been confirmed by a New York bankruptcy court.
To read more
Subscribe to Global Restructuring Review
Register for limited access
Register to receive our newsletter and gain limited access to subscriber content.
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Restructuring Review experts.